Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Repeated greater occipital nerve methylprednisolone injections for chronic cluster headache
NL-OMON56462Phase 3Recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Mar 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of methylprednisolone in Cluster Headache (CH) (2 arms), sponsored by Leiden University Medical Center. Primary endpoint: Retention rate. Started Mar 2023; status: recruiting.
02
Drugs
methylprednisolone
03
Conditions
Cluster Headache (CH)
Beyond the preview
Go deeper on NL-OMON56462.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON56462.